e.g. Tata motors, Reliance MF, 500570

Akums Drugs & Pharmaceuticals Ltd. - Research Center

544222 AKUMS Group (B) BSE data
 
Back to Company Page
Statement:

Balance sheet

(Rs crore)
Mar ' 25 Mar ' 24 Mar ' 23
Sources of funds
Owner's fund
Equity share capital 30.62 28.61 28.61
Share application money - - -
Preference share capital - - -
Reserves & surplus 2,274.63 115.27 282.89
Loan funds
Secured loans 3.93 226.29 145.59
Unsecured loans - - -
Total 2,309.18 370.16 457.09
Uses of funds
Fixed assets
Gross block 667.33 591.96 520.41
Less : revaluation reserve - - -
Less : accumulated depreciation 311.33 274.61 248.01
Net block 356.01 317.35 272.40
Capital work-in-progress 56.74 8.65 16.25
Investments 366.01 138.92 139.16
Net current assets
Current assets, loans & advances 1,906.15 1,630.50 1,466.39
Less : current liabilities & provisions 375.73 1,725.26 1,437.12
Total net current assets 1,530.42 -94.76 29.28
Miscellaneous expenses not written - - -
Total 2,309.18 370.16 457.09
Notes:
Book value of unquoted investments 366.01 138.92 139.16
Market value of quoted investments - - -
Contingent liabilities 31.99 126.48 -
Number of equity sharesoutstanding (Lacs) 1573.94 1430.64 1430.64
Close
Add Akums Drugs & Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Akums Drugs & Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback